Hepatic Arterial Infusion Chemotherapy for Metastatic Breast Cancer Patients With Resistance to Standard Systemic Chemotherapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepatic Arterial Infusion Chemotherapy for Metastatic Breast Cancer Patients With Resistance to Standard Systemic Chemotherapies

Published:2019-12-27 Issue:1 Volume:34 Page:275-282
ISSN:0258-851X
Container-title:In Vivo
language:en
Short-container-title:In Vivo

Author:

FURUTA MITSUHIRO,WATANABE JUNICHIRO,ARAMAKI TAKESHI,NOTSU AKIFUMI,YASUI HIROFUMI

Publisher

Anticancer Research USA Inc.

Subject

Pharmacology,General Biochemistry, Genetics and Molecular Biology,Cancer Research

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of percutaneous arterial port Implantation for Hepatic Arterial Infusion Chemotherapy;European Radiology;2024-07-30

2. Anthracycline-based hepatic arterial infusion chemotherapy achieved 17 months of disease regression in a patient with breast cancer liver metastases resistant to multiple systemic chemotherapies;International Cancer Conference Journal;2024-02-12

3. Role of interventional oncology for treatment of liver metastases: evidence based best practice;The British Journal of Radiology;2022-10-01

4. Hepatic resection for breast cancer related liver metastases: A single institution experience;Scandinavian Journal of Surgery;2022-03

5. Successful Treatment with Hepatic Arterial Infusion Chemotherapy in a Breast Cancer Patient with Multiple Liver Metastases Who Declined Systemic Therapy;Case Reports in Oncology;2021-09-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP